Connection

Jeffrey Jones to Protein-Tyrosine Kinases

Back to Details
This is a "connection" page, showing publications Jeffrey Jones has written about Protein-Tyrosine Kinases.
Jeffrey Jones
Connection Strength
0.203
Protein-Tyrosine Kinases
  1. Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial. Lancet Oncol. 2018 01; 19(1):65-75.
    View in: PubMed
    Score: 0.140
  2. Ibrutinib treatment improves T cell number and function in CLL patients. J Clin Invest. 2017 Aug 01; 127(8):3052-3064.
    View in: PubMed
    Score: 0.034
  3. Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia. JAMA Oncol. 2015 Apr; 1(1):80-7.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.